Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Wecure Pharma Nordic AB
AB
In liquidation
Org 5591625818
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Wecure Pharma Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2019: 0M
0M
2019
2020: 2M
2M
2020
2021: 2M (0% vs 2020)
2M
0%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 1M (-50% vs 2022)
1M
-50%
2023
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
Income statement
SEK thousands
Item
2023
2022
2021
2020
2019
Revenue
1 436
2 201
2 172
1 600
381
Staff expenses
—
—
—
—
—
EBITDA
129
197
230
116
−222
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
129
197
230
116
−222
Net financials
2
—
45
−38
−9
Profit before tax
131
198
274
78
−230
Tax
−24
−41
−26
−0
−0
Net profit
107
157
248
78
−230
Balance sheet
SEK thousands
Item
2023
2022
2021
2020
2019
Total assets
471
1 393
1 245
1 025
1 001
Equity
421
1 114
956
708
630
Long-term debt
0
0
0
0
0
Short-term debt
50
279
288
317
372
Total debt
50
279
288
317
372
Financial ratios
5-year trend
EBITDA margin
9,0 %
This company
15,8 %
Market median
This company
Market median
43% below market
2019
2023
Equity ratio
89,4 %
This company
38,2 %
Market median
This company
Market median
134% above market
2019
2023
Return on equity
25,4 %
This company
18,4 %
Market median
This company
Market median
38% above market
2019
2023
Net profit margin
7,5 %
This company
8,1 %
Market median
This company
Market median
7% below market
2019
2023
Asset turnover
3,05×
This company
1,12×
Market median
This company
Market median
172% above market
2019
2023
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
More on Wecure Pharma Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
